| Martin, Robert |
NCT06526338: Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone |
|
|
| Recruiting | 2 | 126 | US | 1.0% IP-001 for injection, Surgical Resection and Local Ablation, Local Ablation Alone | Robert C. Martin | Hepatocellular Carcinoma | 12/29 | 12/30 | | |
| Completed | 2 | 5 | US | Folfirinox, o Oxaliplatin, o Leucovorin, o Irinotecan, o Fluorouracil, Stereotactic Body Radiation Therapy | University of Louisville, James Graham Brown Cancer Center | Pancreatic Cancer Non-resectable | 03/21 | 03/21 | | |
NCT03080974: Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma |
|
|
| Recruiting | 2 | 10 | US | Nivolumab, Irreversible Electroporation | University of Louisville | Pancreatic Adenocarcinoma | 06/25 | 04/26 | | |
NCT05733598: Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced Unresectable or Metastatic HCC |
|
|
| Recruiting | 2 | 30 | US | RP2, Bevacizumab, Avastin, Atezolizumab, Tecentriq | Replimune Inc., Roche Pharma AG | Hepatocellular Carcinoma | 12/27 | 07/28 | | |
| Active, not recruiting | 1/2 | 42 | Europe, US | 1.0% IP-001 for Injection, IP-001 | Immunophotonics, Inc., Immunophotonics Inc. | Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer, Soft Tissue Sarcoma | 02/25 | 02/25 | | |
NCT03484299: Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma |
|
|
| Recruiting | 1 | 20 | US | Irreversible Electroporation (IRE), Gemcitabine, FOLFIRINOX | University of Louisville | Pancreas Cancer | 12/23 | 07/24 | | |
| Active, not recruiting | N/A | 532 | US | SOC, NanoKnife System | Angiodynamics, Inc. | Stage III Pancreatic Cancer | 12/24 | 12/24 | | |
NCT02674100: American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry |
|
|
| Recruiting | N/A | 500 | Europe, Canada, Japan, US, RoW | Registry | University of Louisville, The Americas Hepato-Pancreato-Biliary Association | Pancreatic Cancer | 01/25 | 01/30 | | |
NCT05953337: Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) |
|
|
| Recruiting | N/A | 120 | US | EYE90 Microspheres Treatment | ABK Biomedical | Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer | 10/25 | 10/25 | | |
CYBRID-02, NCT05520099: Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform |
|
|
| Recruiting | N/A | 216 | US | Core Needle or Forceps Biopsy | Elephas, Hoosier Cancer Research Network | Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer, Cutaneous Melanoma, Endometrial Cancer, Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma | 01/27 | 01/27 | | |
